What is ALR Technologies Inc. (ALRTF)?

ALR Technologies Inc. (ALRTF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of ALRTF?

The current price of ALRTF is $0.02. Prices are updated in real time on Stocks360.

What is ALRTF's price-to-earnings (PE) ratio?

ALRTF's trailing twelve-month PE ratio is -1.35, based on current price and earnings per share data available on Stocks360.

What is ALRTF's market capitalization?

ALRTF's market capitalization is $10,972,936.00, placing it in the small-cap tier.

ALR Technologies Inc. (ALRTF)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.02

Market Cap

$10.97M

PE (TTM)

-1.35

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.34

Day Range

$0.02 – $0.02

52-wk Range

$0.01 – $0.03

Avg Volume

N/A

Volume

30.63K

ALR Technologies Inc. (ALRTF) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $10.97M. Trailing PE -1.35. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-09-16 · $0.01 2026-09-14 · $0.02 (+37.65%)

Earnings

Most Recent

Aug 14, 2013

EPS $-0.00 vs est. $-0.00

Missed by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About ALR Technologies Inc.

ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, includi…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.35×
P/S (TTM)	0.00×
P/B	-0.66×
PEG	0.04×
P/FCF (TTM)	0.00×
EV / EBITDA	-1.96×
EV / Sales	2564.04×
Earnings Yield	-74.13%
Free Cash Flow Yield	0.00%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$19.15M
Revenue (TTM)	$7.47K
Net Income (TTM)	$0.00
Free Cash Flow (TTM)	$1.11M
Net Debt	$19.15M
Working Capital	-$24.31M
Gross Margin	66.22%
Operating Margin	-39448.31%
Net Margin	-159306.37%
Return on Equity	51.64%
Return on Invested Capital	58.36%